Rare diseases
Investigational molecules
Locations
A study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy
ItalyStudy of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure
ItalyStudy of Cenegermin Nasal Spray for Safety and Tolerability in Children with Spastic Cerebral Palsy
ItalyA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
ItalyStudy of GS-4321 for Healthy People and Patients With Chronic Hepatitis Delta Virus Infection
ItalyA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
ItalyStudy of STK-012 Alone and Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
ItalyStudy of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back
ItalyTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
ItalyStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
ItalyA study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia
ItalyA Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
